BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20026981)

  • 1. Interesting image. Two primary colon cancers shown on FDG PET/CT performed to evaluate possible lung metastases from bladder cancer.
    Cui R; Li F; Zhuang H
    Clin Nucl Med; 2010 Jan; 35(1):53-4. PubMed ID: 20026981
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis.
    Chen CJ; Chao TB; Shih DF
    Clin Nucl Med; 2010 Apr; 35(4):258-9. PubMed ID: 20305415
    [No Abstract]   [Full Text] [Related]  

  • 3. Interesting image. Utility of FDG metabolism to differentiate synchronous metastatic liver lesions from synchronous colon cancer: nonmucinous versus mucinous adenocarcinoma.
    Yeh CL; Chen YK
    Clin Nucl Med; 2010 Jan; 35(1):44-6. PubMed ID: 20026977
    [No Abstract]   [Full Text] [Related]  

  • 4. Interesting image. Ameboma mimicking lung cancer on FDG PET/CT.
    Yapar AF; Reyhan M; Canpolat ET
    Clin Nucl Med; 2010 Jan; 35(1):55-6. PubMed ID: 20026982
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interesting image. Correlative imaging with FDG PET-CT and MRI of an unusual recurrence of urothelial cancer in an ileal conduit.
    Purandare NC; Dua S; Shah S; Gupta K; Sharma AR; Rangarajan V
    Clin Nucl Med; 2010 Jan; 35(1):42-3. PubMed ID: 20026976
    [No Abstract]   [Full Text] [Related]  

  • 8. Interesting image. Extrapulmonary small cell carcinoma in prostate: detection with F-18 FDG PET/CT.
    Sayed MH; Farghaly HR; Nguyen NC; Mostafa MS; Mekkawy MA; Osman MM
    Clin Nucl Med; 2010 Jan; 35(1):38-9. PubMed ID: 20026974
    [No Abstract]   [Full Text] [Related]  

  • 9. Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
    Lu SJ; Osmany S; Khoo JB; Ng DC
    Clin Nucl Med; 2010 Apr; 35(4):256-7. PubMed ID: 20305414
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
    Monet A; Merino B; Lupo R
    Clin Nucl Med; 2010 Jan; 35(1):34-5. PubMed ID: 20026972
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
    Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a tubercular fistula-in-ano on F-18 FDG PET/CT.
    Garg G; Tripathi M; D'Souza M; Jaimini A; Jain N; Khurana A; Sharma R; Mondal A
    Clin Nucl Med; 2010 Apr; 35(4):300-2. PubMed ID: 20305432
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.
    Hung GU; Hsiung CY; Huang ML; Lin ST
    Clin Nucl Med; 2009 Dec; 34(12):962-3. PubMed ID: 20139852
    [No Abstract]   [Full Text] [Related]  

  • 17. FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer.
    Osman MM; Altinyay ME; Abdelmalik AG; Brickman TM; Varvares MA; Nguyen NC
    Clin Nucl Med; 2011 Jun; 36(6):496-7. PubMed ID: 21552038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.